2
LEO Foundation Annual Report 2020
LEO Foundation at a glance
Management review
LEO Foundation at a glance
How we work At the LEO Foundation we create sustainable value for people and society through engaged ownership, philanthropy and investments.
A BO U T T H E L E O GR OUP The LEO Group consists of the LEO Foundation, LEO Holding A/S and LEO Pharma A/S, including its Danish and international subsidiaries (collectively LEO Pharma Group).
LEO Foundation
LEO Holding A/S
WHO WE AR E The LEO Foundation is one of Denmark’s largest commercial foundations. The Foundation is the controlling owner of the pharmaceutical company LEO Pharma and its main objective is to ensure the company’s long-term development and success.
LEO Pharma Group
LEO Foundation The LEO Foundation was established in 1984. The Foundation is the ultimate controlling shareholder of LEO Pharma and provides philanthropic support to independent research. LEO Holding The LEO Foundation’s financial assets are held in LEO Holding where all investment activities are carried out. LEO Pharma Group LEO Pharma develops, manufactures and markets pharmaceutical drugs for the treatment of skin diseases in more than 130 countries.
E NGAGE D O W NE RSH I P We are an engaged owner of LEO Pharma and support the company’s development as a global leader in dermatology, delivering outstanding results.
I NVE STM E NTS
DKK 16 billion in financial assets We grow our financial assets to ensure continued capability to support LEO Pharma’s long-term development and provide funds for philanthropic activities.
Financial statements
PHILANTHROPY
25 grants and awards in 2020 A total of DKK 72 million We support the best international research in skin diseases and aim to make Denmark a global beacon for skin research.
